Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Knop

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Blood|December 14, 2011
From the observation DAC: romidepsin revisitedStefan Knop
Onkologie|September 22, 2011
Continuous treatment in multiple myeloma - ready for prime time?Stefan Knop
Medizinische Monatsschrift Fur Pharmazeuten|April 19, 2014
[The multiple myeloma--current view and perspectives]Stefan Knop
Oncology Research and Treatment|November 18, 2021
Updated Perspectives on the Management of Relapsed and Refractory Multiple MyelomaLinda Heimberg, Stefan Knop
Expert Review of Hematology|July 10, 2019
Are triplet therapies really living up to their hype as the "standard of care" for multiple myeloma and what else is needed?Martin Schreder, Stefan Knop
Haematologica|December 1, 2022
What about (MG)US? Towards tailored testing in monoclonal gammopathiesFriederike Bachmann, Stefan Knop
Future Oncology (London, England)|July 31, 2018
The role of carfilzomib in treatment of newly diagnosed multiple myelomaSusanne Strifler, Stefan Knop
Future Oncology (London, England)|December 23, 2010
Novel agents to improve outcome of allogeneic transplantation for patients with multiple myelomaMartin Kortüm, Stefan Knop, Hermann Einsele
Lancet (London, England)|December 27, 2014
Multiple myelomaChristoph Röllig, Stefan Knop, Martin Bornhäuser
Clinical Nuclear Medicine|May 31, 2014
FDG PET/CT depicts cutaneous plasmocytomaConstantin Lapa, Stefan Knop, Katharina Lückerath
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Blood|December 14, 2011
From the observation DAC: romidepsin revisitedStefan Knop
Onkologie|September 22, 2011
Continuous treatment in multiple myeloma - ready for prime time?Stefan Knop
Medizinische Monatsschrift Fur Pharmazeuten|April 19, 2014
[The multiple myeloma--current view and perspectives]Stefan Knop
Oncology Research and Treatment|November 18, 2021
Updated Perspectives on the Management of Relapsed and Refractory Multiple MyelomaLinda Heimberg, Stefan Knop
Expert Review of Hematology|July 10, 2019
Are triplet therapies really living up to their hype as the "standard of care" for multiple myeloma and what else is needed?Martin Schreder, Stefan Knop
Haematologica|December 1, 2022
What about (MG)US? Towards tailored testing in monoclonal gammopathiesFriederike Bachmann, Stefan Knop
Future Oncology (London, England)|July 31, 2018
The role of carfilzomib in treatment of newly diagnosed multiple myelomaSusanne Strifler, Stefan Knop
Future Oncology (London, England)|December 23, 2010
Novel agents to improve outcome of allogeneic transplantation for patients with multiple myelomaMartin Kortüm, Stefan Knop, Hermann Einsele
Lancet (London, England)|December 27, 2014
Multiple myelomaChristoph Röllig, Stefan Knop, Martin Bornhäuser
Clinical Nuclear Medicine|May 31, 2014
FDG PET/CT depicts cutaneous plasmocytomaConstantin Lapa, Stefan Knop, Katharina Lückerath
Pageof 14